Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Size: px
Start display at page:

Download "Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416)."

Transcription

1 Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52 (24.5) 144 (29.6) 490 (38.6) 1017 (41.7) women 160 (75.5) 343 (70.4) 786 (61.6) 1424 (58.3) Age (years); median (interquartile range (, 58.0 (19.75) 53.0 (21.0) 51.0 (22.0) 56.0 (23.0) IQR)) Education (years of schooling); 12.0 (4.0) 12.0 (3.0) 12.0 (3.0) 12.0 (4.0) median (IQR) Material status; median (IQR) 11.0 (4.0) 11.0 (4.0) 11.0 (4.0) 10.0 (4.0) Smoking; n (%) current smokers 41 (19.3) 115 (23.6) 361 (28.3) 690 (28.3) ex-smokers 55 (25.9) 114 (23.4) 315 (24.7) 636 (26.1) never-smokers 116 (54.7) 258 (53.0) 600 (47.0) 1115 (45.7) Alcohol intake; n (%) excessive 32 (15.1) 70 (14.4) 225 (17.6) 437 (17.9) moderate 90 (42.5) 248 (50.9) 631 (49.5) 1069 (43.8) none 90 (42.5) 169 (34.7) 420 (32.9) 935 (38.3) MDSS 14 points; n (%) 147 (69.3) 189 (38.8) 301 (23.6) 637 (26.1) Physical activity; n (%) light 51 (24.1) 122 (25.1) 304 (23.8) 612 (25.1) moderate 147 (69.3) 342 (70.2) 852 (66.8) 1532 (62.8) intensive 14 (6.6) 23 (4.7) 120 (9.4) 295 (12.1) BMI (kg/m 2 ); n (%) 25.0 (normal) 102 (48.1) 242 (49.7) 605 (47.4) 984 (40.3) (overweight) 83 (39.2) 172 (35.3) 464 (36.4) 971 (39.8) 30.0 (obese) 27 (12.7) 73 (15.0) 207 (16.2) 486 (19.9) Waist circumference ( 94 cm, 80cm ); n (%) 169 (80.1) 360 (74.2) 919 (72.5) 1909 (78.9) WHR ( 0.90, 0.85 ); n (%) 137 (64.9) 296 (61.0) 805 (63.6) 1800 (74.6) Overall pp (post-hoc test p-vp values) <0.001 (0.173 DW, <0.001 DM, <0.001 DN WM, <0.001 WN, MN ) <0.001 (<0.001 DW, <0.001 DM, DN WM, <0.001 WN, <0.001 (0.438 DW, DM, <0.001 DN WM, <0.001 WN, <0.001 (0.073 DW, DM, <0.001 DN, WM, <0.001 WN, (0.431 DW, DM, DN, WM, WN, MN ) (0.098 DW, DM, DN, WM, WN, MN ) <0.001 (<0.001 DW, <0.001 DM, <0.001 DN, <0.001 WM, <0.001 WN, MN ) <0.001 (0.588 DW, DM, DN, WM, <0.001 WN, MN ) <0.001 (0.550 DW, DM, DN, WM, <0.001 WN, <0.001 (0.096 DW, DM, DN, WM, WN, <0.001 (0.330 DW, DM, DN, WM, <0.001 WN,

2 WHtR ( 0.5); n % 159 (75.4) 348 (71.8) 932 (73.6) 1975 (81.7) Cholesterol ( 5 mmol/l); n (%) HDL ( 1.03 mmol/l, 1.29 mmol/l ); n (%) 164 (77.4) 378 (77.6) 892 (69.9) 1841 (75.4) 35 (16.5) 95 (19.5) 231 (18.1) 493 (20.2) LDL ( 3 mmol/l); n (%) 158 (74.5) 377 (77.4) 884 (69.3) 1795 (73.5) Triglycerides ( 1.7 mmol/l); n (%) 41 (19.3) 106 (21.8) 302 (23.7) 714 (29.3) CHD; n (%) 13 (6.1) 25 (5.1) 59 (4.6) 244 (10.0) CVI; n (%) 4 (1.9) 8 (1.6) 17 (1.3) 66 (2.7) Hypertension (Systolic 140 mmhg or Diastolic 90 mmhg or treated for hypertension); n (%) Diabetes ( 7 mmol/l or treated for diabetes type 2); n (%) HbA1c ( 6.5 mmol/l or treated for diabetes); n (%) 73 (34.4) 141 (29.0) 391 (30.7) 896 (36.8) 20 (9.4) 39 (8.0) 105 (8.2) 318 (13.0) 19 (9.0) 35 (7.2) 85 (6.7) 255 (10.4) Metabolic syndrome; n (%) 87 (42.6) 189 (39.5) 471 (39.0) 1258 (52.3) Gout (Uric acid 404 μmol/l, 338 μmol/l or gout); n (%) 34 (16.9) 71 (15.0) 191 (16.0) 513 (21.6) <0.001 (0.326 DW, DM, DN, WM, <0.001 WN, <0.001 (0.940 DW, DM, DN, WM, WN, (0.349 DW, DM, DN, WM, WN, MN ) (0.408 DW, DM, DN, WM, WN, MN ) <0.001 (0.469 DW, DM, DN, WM, WN, <0.001 (0.592 DW, DM, DN, WM, WN, (0.819 DW, DM, DN, WM, WN, MN ) <0.001 (0.148 DW, DM, DN, WM, WN, <0.001 (0.533 DW, DM, DN, WM, WN, (0.419 DW, DM, DN, WM, WN, <0.001 (0.449 DW, DM, DN, WM, <0.001 WN, <0.001 (0.526 DW, DM, DN, WM, WN, MDSS - Mediterranean Diet Serving Score. BMI - body mass index. WHR waist-to-hip ratio. WHtR waist-to-height ratio. CHD - coronary heart disease. CVI - cerebrovascular insult. : males. : woman. p-values for categorical variables were obtained with chi-squared test, and for numerical with Kruskal-Wallis test. Post-hoc test P p-values values for categorical variables were obtained with chi-squared test, and for numerical with Mann-Whitney U test. DW Post-hoc test Pp-V value: Daily daily vs. Weeklyweekly. DM Post-hoc test p- value: Daily daily vs. Monthlymonthly. DN Post-hoc test p- value: Daily daily vs. Nevernever. WM Post-hoc test p- value: Weekly weekly vs. Monthlymonthly. WN Post-hoc test p- value: Weekly weekly vs. Infrequentlyinfrequently or never. MN Post-hoc test p- value: Monthly monthly vs. Infrequentlyinfrequently or never.

3 Formatted: MDPI_3.1_text Table S2. Characteristics associated with unfavorable biochemical parameters; lipid levels as determined by the multivariate logistic regression models and elevated fibrinogen as determined by ordinal regression model (sample size is 897 participants subjects without previous cardiovascular diseasecvd diagnosis and older than 65 years of age; all independent variables included in the model are listed in the table). Sex (referent ([ref)]: female) Cholesterol ( 5 mmol/l) confidence interval); Pp-Value LDL ( 3 mmol/l) HDL ( 1.03 mmol/l, 1.29 mmol/l ) Triglycerides ( 1.7 mmol/l) Fibrinogen ( 4.0 g/l is referent) male 0.67 ( ); ( ); ( ); < ( ); ( ); Age (years) median (interquartile range (IQR)) Place of residence (ref: Split) 0.96 ( ); ( ); ( ); ( ); ( ); Island of Vis 2.07 ( ); ( ); ( ); < ( ); ( ); <0.001 Island of Korčula 1.20 ( ); ( ); ( ); < ( ); < ( ); <0.001 Education (years of schooling, ref: 13) Overall Pp = Overall p = P=0.043 Overall p = P=0.294 Overall p = P= ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); Material status (ref: 4th quartile) Overall p = P=0.624 Overall p = P=0.055 Overall p = P=0.107 Overall p = P= st quartile 1.47 ( ); ( ); ( ); ( ); ( ); nd quartile 1.32 ( ); ( ); ( ); ( ); ( ); rd quartile 1.12 ( ); ( ); ( ); ( ); ( ); Smoking (ref: never-smokers) Overall p = P=0.803 Overall p = P=0.408 Overall p = P=0.806 Overall p = P= current smokers 0.94( ); ( ); ( ); ( ); ( ); ex-smokers 0.85 ( ); ( ); ( ); ( ); ( ); Alcohol intake (ref: none) Overall p = P=0.196 Overall p = P=0.504 Overall p = P=0.182 Overall p = P= excessive 1.74 ( ); ( ); ( ); ( ); ( ); moderate 1.01 ( ); ( ); ( ); ( ); ( ); MDSS compliance (ref: yes) no 0.86 ( ); ( ); ( ); ( ); ( ); Nut (ref: infrequently or never) Overall p = P=0.350 Overall p = P=0.470 Overall p = P=0.142 Overall p = P=0.303 daily 1.71 ( ); ( ); ( ); ( ); ( ); weekly 1.79 ( ); ( ); ( ); ( ); ( ); monthly 1.21 ( ); ( ); ( ); ( ); ( ); Physical activity (ref: intensive) Overall p = P=0.689 Overall p = P=0.610 Overall P= p = Overall p = P= Formatted: Font: Italic Formatted: Left Formatted: Font: Italic

4 light 1.00 ( ); ( ); ( ); ( ); ( ); moderate 0.83 ( ); ( ); ( ); ( ); ( ); WHtR ( 0.5, ref: yes) no 0.47 ( ); ( ); ( ); ( ); ( ); Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension, ref: yes) no 0.76 ( ); ( ); ( ); ( ); ( ); Diabetes ( 7 mmol/l or treated for diabetes type 2, ref: yes) no 1.89 ( ); ( ); ( ); ( ); ( ); Gout (uric acid 404 μmol/l, 338 μmol/l or gout, ref: yes) no 1.47 ( ); ( ); ( ); ( ); < ( ); MDSS - Mediterranean Diet Serving Score. WHtR - waist-to-height ratio. : males. : woman. Multivariate logistic regression models were built separately for cholesterol, LDL, HDL and triglycerides. Multivariate ordinal regression model was used for the analysis of the characteristics associated with elevated fibrinogen. Adjusted odds ratios, 95% confidence intervals and p-values were calculated using multivariate regression models; each of the five models presented here was simultaneously adjusted for all the covariates listed in this table. Table S3. Characteristics associated with hypertension, diabetes, metabolic syndrome and gout as determined by the multivariate logistic regression analyses (sample size is 897 participants subjects without previous cardiovascular disease CVD diagnosis and older than 65 years of age; all independent variables included in the model are listed in the table). Sex (referent ([ref)]: female) Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension) Diabetes ( 7 mmol/l or treated for diabetes type 2) Elevated HbA1c ( 6.5 mmol/l or treated for diabetes type 2) Metabolic syndrome Gout (uric acid 404 mmol/l mmol/l or gout) male 1.29 ( ); ( ); ( ); ( ); < ( ); Age (years) 0.99 ( ); ( ); ( ); ( ); ( ); Place of residence (ref: Split) Island of Vis 0.59 ( ); ( ); ( ); ( ); ( ); Island of Korčula 1.07 ( ); ( ); ( ); ( ); ( ); Education (years of schooling, ref: 13) Overall p = P=0.007 Overall p = P=0.150 Overall p = P=0.417 Overall p = P=0.653 Overall p = P= ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); ( ); 0.106

5 Material status (ref: 4th quartile) Overall p = P=0.497 Overall p = P=0.031 Overall p = P=0.092 Overall p = P=0.444 Overall p = P= st quartile 0.81 ( ); ( ); ( ); ( ); ( ); nd quartile 0.88 ( ); ( ); ( ); ( ); ( ); rd quartile 0.68 ( ); ( ); ( ); ( ); ( ); Smoking (ref: never-smokers) Overall p = P=0.210 Overall p = P=0.166 Overall p = P=0.347 Overall p = P=0.549 Overall p = P=0.005 current smokers 1.11 ( ); ( ); ( ); ( ); ( ); ex-smokers 0.75 ( ); ( ); ( ); ( ); ( ); Alcohol intake (ref: none) Overall p = P=0.474 Overall p = P=0.473 Overall p = P=0.496 Overall p = P=0.009 Overall p = P=0.220 excessive 0.73 ( ); ( ); ( ); ( ); ( ); moderate 0.92 ( ); ( ); ( ); ( ); ( ); MDSS compliance (ref: yes) no 1.34 ( ); ( ); ( ); ( ); ( ); Nut (ref: infrequently or never) Overall p = P=0.496 Overall p = P=0.583 Overall p = P=0.051 Overall p = P=0.659 Overall p = P=0.968 daily 0.97 ( ); ( ); ( ); ( ); ( ); weekly 1.18 ( ); ( ); ( ); ( ); ( ); monthly 1.32 ( ); ( ); ( ); ( ); ( ); Physical activity (ref: intensive) Overall p = P=0.770 Overall p = P=0.291 Overall p = P=0.336 Overall p = P=0.484 Overall p = P=0.112 light 0.97 ( ); ( ); ( ); ( ); ( ); moderate 0.88 ( ); ( ); ( ); ( ); ( ); WHtR ( 0.5, ref: yes) no 0.61 ( ); ( ); ( ); ( ); < ( ); Hypertension (systolic 140 mmhg or diastolic 90 mmhg or treated for hypertension, ref: yes) no nna 0.67 ( ); ( ); ( ); < ( ); <0.001 Diabetes ( 7 mmol/l or treated for diabetes type 2, ref: yes) no 0.68 ( ); na na 0.21 ( ); < ( ); Metabolic syndrome (ref: yes) no 0.47 ( ); < ( ); < ( ); <0.001 na 0.56 ( ); Gout (uric acid 404 μmol/l μmol/l or gout); yes is referent Formatted Table

6 no 0.50 ( ); < ( ); ( ); ( ); na MDSS - Mediterranean Diet Serving Score. WHtR waist-to-height ratio. na not applicable. : males. : woman. Multivariate logistic regression models were built separately for hypertension, diabetes, metabolic syndrome and gout. Adjusted odds ratios, 95% confidence intervals and p-vp values were calculated using multivariate logistic regression; each of the four models was simultaneously adjusted for all covariates listed in this table, with an exception of excluding predictor variables in models where those variables were the outcome variables (marked with na ). Formatted: Space After: 6 pt, Line spacing: At least 13 pt Formatted: Font: 9 pt, Font color: Black Formatted: MDPI_4.3_table_footer

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?

WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed

More information

Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.

Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. Obstructive sleep apnoea and retinopathy in patients with type 2 diabetes Altaf, Quratul-ain; Dodson, Paul; Ali, Asad; Raymond, Neil T; Wharton, Helen; Hampshire- Bancroft, Rachel; Shah, Mirriam; Shepherd,

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight. Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Cardiovascular Disease Risk Behaviors of Nursing Students in Nursing School

Cardiovascular Disease Risk Behaviors of Nursing Students in Nursing School International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Logistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions

Logistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions Logistic Regression Predicting the Chances of Coronary Heart Disease Multivariate Solutions What is Logistic Regression? Logistic regression in a nutshell: Logistic regression is used for prediction of

More information

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

AUTONOMIC FUNCTION IS A HIGH PRIORITY

AUTONOMIC FUNCTION IS A HIGH PRIORITY AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Basic Biostatistics. Chapter 1. Content

Basic Biostatistics. Chapter 1. Content Chapter 1 Basic Biostatistics Jamalludin Ab Rahman MD MPH Department of Community Medicine Kulliyyah of Medicine Content 2 Basic premises variables, level of measurements, probability distribution Descriptive

More information

Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:

Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories: Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit

More information

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the

More information

ASSeSSing the risk of fatal cardiovascular disease

ASSeSSing the risk of fatal cardiovascular disease ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril

More information

APPENDIX AVAILABLE ON THE HEI WEB SITE

APPENDIX AVAILABLE ON THE HEI WEB SITE APPENDIX AVAILABLE ON THE HEI WEB SITE Research Report 178 National Particle Component Toxicity (NPACT) Initiative Report on Cardiovascular Effects Sverre Vedal et al. Section 1: NPACT Epidemiologic Study

More information

Trends In CVD, Related Risk Factors, Prevention and Control In China

Trends In CVD, Related Risk Factors, Prevention and Control In China Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,

More information

290 Biomed Environ Sci, 2016; 29(4):

290 Biomed Environ Sci, 2016; 29(4): 290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur

More information

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

programme. The DE-PLAN follow up.

programme. The DE-PLAN follow up. What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa

More information

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

CARE PATHWAYS. Allyson Ashley

CARE PATHWAYS. Allyson Ashley CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Supplementary Table 1. The distribution of IFNL rs and rs and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC

Supplementary Table 1. The distribution of IFNL rs and rs and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC Supplementary Table 1. The distribution of IFNL rs12979860 and rs8099917 and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC rs12979860 (n=3129) CC 1127 1145.8 CT 1533 1495.3 TT

More information

Prevalence of Comorbidities among HIV-positive patients in Taiwan

Prevalence of Comorbidities among HIV-positive patients in Taiwan Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity

More information

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori

More information

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution

More information

300 Biomed Environ Sci, 2018; 31(4):

300 Biomed Environ Sci, 2018; 31(4): 300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the

More information

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,

More information

902 Biomed Environ Sci, 2014; 27(11):

902 Biomed Environ Sci, 2014; 27(11): 902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,

PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, MD,PhD,FRCP(Lond),FESC,FACC University Hospital Center

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

ARIC Manuscript Proposal # 1518

ARIC Manuscript Proposal # 1518 ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in

More information

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D. Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could

More information

Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan

Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan 1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,

More information

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions

More information

How to Reduce CVD Complications in Diabetes?

How to Reduce CVD Complications in Diabetes? How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT Siti Hajar MH 1, Harmy MY 1, Norhayati MN 1, Aida HGR 2, Hamid JJM 3 Department

More information

LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME

LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman

More information

Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary

Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary World Journal of Medical Sciences 9 (4): 282-288, 2013 ISSN 1817-3055 IDOSI Publications, 2013 DOI: 10.5829/idosi.wjms.2013.9.4.12383 Effect of Combined Interventions of Diet and Physical Activity on the

More information

The State of Play of Diabetes Indicators

The State of Play of Diabetes Indicators The State of Play of Diabetes Indicators South Australian and National Information Catherine Chittleborough Janet Grant Anne Taylor April 2003 Diabetes Clearing House Population Research and Outcome Studies

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study

Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study Meriam F. Caboral,, RN, MSN, NP-C Clinical Coordinator Heart Failure Components

More information

PREVALENCE OF AND FACTORS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN A COHORT OF ADULTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS.

PREVALENCE OF AND FACTORS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN A COHORT OF ADULTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS. PREVALENCE OF AND FACTORS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA IN A COHORT OF ADULTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS by Hristina Denić BS in Nursing, Indiana University of Pennsylvania,

More information

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: the DEMAND (Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes) Study. Rossi

More information

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,

More information

Diabetes and Cardiovascular risk factors among Oil Sector Workers in the State of Kuwait (2013 KOC Periodical Medical Exam.)

Diabetes and Cardiovascular risk factors among Oil Sector Workers in the State of Kuwait (2013 KOC Periodical Medical Exam.) Diabetes and Cardiovascular risk factors among Oil Sector Workers in the State of Kuwait (2013 KOC Periodical Medical Exam.) Mohammad Hasan, RN, CMIOSH Brief about KOC Kuwait Oil Company (KOC) is a state

More information

Relationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure

Relationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure World Journal of Cardiovascular Diseases, 2013, 3, 234-238 http://dx.doi.org/10.4236/wjcd.2013.32036 Published Online April 2013 (http://www.scirp.org/journal/wjcd/) WJCD Relationship between cardiovascular

More information

Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD)

Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) Researchers: Kevin Mc Namara (Principal Investigator), Dr Stephen Bunker, Prof James Dunbar, Gregory Duncan,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery

More information

Choosing the Correct Statistical Test

Choosing the Correct Statistical Test Choosing the Correct Statistical Test T racie O. Afifi, PhD Departments of Community Health Sciences & Psychiatry University of Manitoba Department of Community Health Sciences COLLEGE OF MEDICINE, FACULTY

More information

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? W.H. OLDEWAGE-THERON & A.A. EGAL Centre of Sustainable Livelihoods, Vaal University of Technology,

More information

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira

More information

Rationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source:

Rationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source: GSK Medicine: N/A Study No.: 112255 Title: A Korean, multi-center, nation-wide, cross-sectional, epidemiology study to identify prevalence of diabetic nephropathy in hypertensive patients with type 2 diabetes

More information

Obesity Prevention and Control: Provider Education with Patient Intervention

Obesity Prevention and Control: Provider Education with Patient Intervention Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist

More information

Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group

Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,

More information

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Epidemiology and Prevention

Epidemiology and Prevention Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and

More information

Supplementary Note Details of the patient populations studied Strengths and weakness of the study

Supplementary Note Details of the patient populations studied Strengths and weakness of the study Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined

More information

SITA 100 mg (n = 378)

SITA 100 mg (n = 378) Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,

More information

Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes

Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes Gender Differences in Physical Inactivity and Cardiac Events in Men and Women with Type 2 Diabetes Margaret M. McCarthy 1 Lawrence Young 2 Silvio Inzucchi 2 Janice Davey 2 Frans J Th Wackers 2 Deborah

More information

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe

More information

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,

More information